Fibrin-related markers in patients with septic shock: Individual comparison of D-dimers and fibrin monomers impacts on prognosis

• References

• 1 Gris JC, Faillie JL, Cochery-Nouvellon E. et al. ISTH overt DIC score in patients with septic shock: automated immunoturbidimetric soluble fibrin assay versus D-dimer assay. J Thromb Haemost 2011; 9: 1252-1255.
• 2 Thijs LG, de Boer JP, de Groot MC. et al. Coagulation disorders in septic shock. Intensive Care Med 1993; 19 (Suppl. 02) S8-15.
• 3 Massignon D, Lepape A, Bienvenu J. et al. Coagulation/fibrinolysis balance in septic shock related to cytokines and clinical state. Haemostasis 1994; 2: 36-48.
• 4 Kidokoro A, Iba T, Fukunaga M. et al. Alterations in coagulation and fibrinolysis during sepsis. Shock 1996; 5: 223-228.
• 5 Vervloet MG, Thijs LG, Hack CE. Derangements of coagulation and fibrinolysis in critically ill patients with sepsis and septic shock. Sem Thromb Hemost 1998; 24: 33-44.
• 6 Zeerleder S, Schroeder V, Hack CE. et al. TAFI and PAI-1 levels in human sepsis. Thromb Res 2006; 118: 205-212.
• 7 Hartemink KJ, Hack CE, Groeneveld AB. Relation between coagulation/fibrinolysis and lactate in the course of human septic shock. J Clin Pathol 2010; 63: 1021-1026.
• 8 Friederich PW, Levi M, Biemond BJ. et al. Novel low-molecualr-weight inhibitor of PAI-1 (XR5118) promotes endogenous fibrinolysis and reduces postthrombolysis thrombi growth in rabbits. Circulation 1997; 96: 916-921.